Tradename | Company | Number | Date | Products |
---|---|---|---|---|
PLENVU | Salix Pharmaceuticals | N-209381 RX | 2018-05-04 | 1 products, RLD, RS |
MOVIPREP | Salix Pharmaceuticals | N-021881 RX | 2006-08-02 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ASCOR | McGuff Pharmaceuticals | N-209112 RX | 2017-10-02 | 1 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
acetaminophen, ascorbic acid, chlorpheniramine maleate | Export only | 2024-05-08 |
allevia | unapproved drug other | 2025-02-27 |
anubis barcelona | OTC monograph final | 2023-09-01 |
aoao snow bieach intensive for face and body | C200263 | 2024-10-18 |
aoao whitening cream | C200263 | 2024-10-13 |
aromacura shower filter | unapproved drug other | 2021-01-05 |
aronamin gold | unapproved drug other | 2018-12-12 |
ascor | New Drug Application | 2024-12-04 |
ascor l 500 | Export only | 2017-04-04 |
ascorbyl palmitate 2% / hyaluronic acid sodium salt 0.2% / niacinamide 5% / tretinoin 0.025% | unapproved drug other | 2019-05-17 |
Expiration | Code | ||
---|---|---|---|
ASCORBIC ACID, ASCOR, MCGUFF | |||
2024-10-02 | ODE-160 |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate, Plenvu, Salix | |||
8999313 | 2033-09-10 | DP | |
9326969 | 2033-09-10 | U-2310 | |
9707297 | 2033-09-10 | DP | |
10016504 | 2033-09-10 | DP | |
10918723 | 2033-09-10 | U-2310 | |
9592252 | 2032-08-11 | DP | U-2310 |
10646512 | 2032-03-25 | DP | |
10780112 | 2032-03-09 | DP | |
10792306 | 2032-03-09 | DP | U-2310 |
11529368 | 2032-03-09 | DP | U-2310 |
Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate, Moviprep, Salix Pharms | |||
7169381 | 2024-09-01 | DS, DP | |
7658914 | 2024-09-01 | DS, DP |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hepatitis | D006505 | — | K75.9 | 1 | — | — | 1 | — | 2 |
Hepatitis a | D006506 | EFO_0007305 | B15 | 1 | — | — | 1 | — | 2 |
Hepatitis c | D006526 | — | B19.2 | — | — | — | 1 | — | 1 |
Chronic hepatitis c | D019698 | EFO_0004220 | B18.2 | — | — | — | 1 | — | 1 |
Chronic hepatitis | D006521 | — | K73.9 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hepatitis b | D006509 | — | — | 1 | — | — | — | — | 1 |
Chronic hepatitis b | D019694 | EFO_0004239 | B18.1 | 1 | — | — | — | — | 1 |
Drug common name | Ascorbic acid |
INN | ascorbic acid |
Description | L-ascorbic acid is the L-enantiomer of ascorbic acid and conjugate acid of L-ascorbate. It has a role as a coenzyme, a flour treatment agent, a food antioxidant, a plant metabolite, a cofactor, a skin lightening agent, a geroprotector and a food colour retention agent. It is an ascorbic acid and a vitamin C. It is a conjugate acid of a L-ascorbate. It is an enantiomer of a D-ascorbic acid. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | O=C1O[C@H]([C@@H](O)CO)C(O)=C1O |
PDB | — |
CAS-ID | 50-81-7 |
RxCUI | — |
ChEMBL ID | CHEMBL196 |
ChEBI ID | 29073 |
PubChem CID | 54670067 |
DrugBank | DB00126 |
UNII ID | PQ6CK8PD0R (ChemIDplus, GSRS) |